DPYSL5 is highly expressed in treatment-induced neuroendocrine prostate cancer and promotes lineage plasticity via EZH2/PRC2.
Kaarijärvi R, Kaljunen H, Nappi L, Fazli L, Kung SHY, Hartikainen JM, Paakinaho V, Capra J, Rilla K, Malinen M, Mäkinen PI, Ylä-Herttuala S, Zoubeidi A, Wang Y, Gleave ME, Hiltunen M, Ketola K.
Kaarijärvi R, et al. Among authors: hiltunen m.
Commun Biol. 2024 Jan 18;7(1):108. doi: 10.1038/s42003-023-05741-x.
Commun Biol. 2024.
PMID: 38238517
Free PMC article.